Latest Advances

  • Condition: Botulism
  • Journal: JCI insight
  • Treatment Used: 3,4-DAP
  • Number of Patients: 0
  • Published —
The study researched the safety and effectiveness of 3,4-DAP for treating symptoms of botulism.
  • Condition: Male Patients with Idiopathic Overactive Bladder Syndrome
  • Journal: The Journal of urology
  • Treatment Used: Intradetrusor OnabotulinumtoxinA Injection
  • Number of Patients: 146
  • Published —
This study assessed the treatment response, complications and treatment continuation after onabotulinumtoxinA injection in male patients.
  • Condition: Botulism
  • Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • Treatment Used: Equine-derived Heptavalent Botulinum Antitoxin Treatment
  • Number of Patients: 162
  • Published —
The study researched the effects of an equine-derived heptavalent botulinum antitoxin treatment for treating botulism.
  • Condition: Botulism poisoning
  • Journal: The Cochrane database of systematic reviews
  • Treatment Used: Medical treatment in addition to intensive care: botulism antitoxin, botulism antibodies, and guanidine
  • Number of Patients: 122
  • Published —
To assess the effects of medical treatment on the rate of mortality, number of days in the hospital, breathing tube needs, feeding tube or intravenous nutrition, and risk of adverse events
  • Condition: Post-Stroke Upper Limb Spasticity
  • Journal: Archives of physical medicine and rehabilitation
  • Treatment Used: Extracorporeal Shock Waves (ESWT) vs. Botulinum Toxin Type A (BoNT-A)
  • Number of Patients: 42
  • Published —
This study investigated whether extracorporeal shock wave therapy (ESWT) is non-inferior to botulinum toxin type A (BoNT-A) for the treatment of post-stroke upper limb spasticity.
Showing 1-5 of 5